access to justice
Medical Devices
Prescription Drugs
Vehicle Accidents
Women’s Health
Home » FDA, Prescription Drugs

FDA finds bits of steel, rubber in Genzyme drugs

Submitted by on November 16, 2009 – 1:20 pmNo Comment | 27 views

FDA finds bits of steel, rubber in Genzyme drugs

The San Francisco Chronicle reports that Food and Drug Administration said Friday that bits of steel, rubber and fiber found in vials of drugs used to treat rare enzyme disorders could cause serious adverse health effects for patients. Despite those problems, the FDA said the products would remain on the market, because there are few alternative treatments.

FDA regulators say doctors should closely inspect vials for particles before injecting them into patients. Doctors should return the product to Genzyme if they suspect contamination, the agency said. Physicians should also watch for potential allergic reactions, blood clots and other problems in patients.

Related posts:

  1. Allergan suing FDA over off-label policy
  2. FDA cracks down on Internet sales of swine flu ‘cures’
  3. FDA fails to follow up on unproven drugs
  4. Document Details Forest Labs’ Plan to Promote Costly Drug Lexapro
  5. Study ties common antibiotics with birth defects